Company Filing History:
Years Active: 2016-2018
Title: Diedre MacKenna: Innovator in Metabolic Disorder Treatments
Introduction
Diedre MacKenna is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of biotechnology, particularly in the treatment of metabolic disorders. With a total of three patents to her name, her work focuses on innovative solutions that address critical health issues.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Targeting microRNAs for metabolic disorders." This patent describes compounds comprising modified oligonucleotides that are complementary to miR-103 and/or miR-107. The methods outlined in this patent aim to treat various diseases and disorders using these compounds. This innovative approach highlights her commitment to advancing medical science and improving patient outcomes.
Career Highlights
Diedre MacKenna has established herself as a key figure in her field through her work at Regulus Therapeutics Inc. Her research and inventions have garnered attention for their potential impact on treating metabolic disorders. Her dedication to innovation is evident in her successful patent applications and the scientific advancements they represent.
Collaborations
Diedre collaborates with esteemed colleagues, including Balkrishen Bhat and Neil W Gibson. These partnerships enhance her research efforts and contribute to the development of effective treatments in the biotechnology sector.
Conclusion
Diedre MacKenna is a trailblazer in the field of metabolic disorder treatments, with her innovative patents paving the way for future advancements. Her work exemplifies the importance of research and collaboration in addressing complex health challenges.